2d
Clinical Trials Arena on MSNHelicore doses first subject in Phase I trial of obesity treatmentUS-based biopharmaceutical company Helicore Biopharma has dosed the first subject in a randomised, first-in-human Phase I ...
G Protein-Coupled Receptors (GPCRs) in advancing GPCR-targeted therapies, including the use of agonists, antagonists, biased ...
Hosted on MSN3mon
Proteomics method identifies ligand-binding proteins and binding sites in complex systemsKnowledge of the ligand-binding regions is also extremely valuable for structure-based drug design and biological hypothesis generation. Traditional methods for determining binding sites and ...
A novel protein cage system can control and visualize orientational changes in aromatic side chains upon ligand binding. By inducing coordinated molecular changes, this approach enables precise ...
Get Instant Summarized Text (Gist) A novel protein cage system enables control and visualization of aromatic side chain orientation changes upon ligand binding, enhancing fluorescence properties ...
PARP7 is a mono-ADP-ribosyl transferase (mono-ART) which has recently gained attention due to its emerging role as a negative ...
12d
News-Medical.Net on MSNNovel cyclic peptide antagonist can be a promising therapeutic approach for MASHThe farnesoid X receptor (FXR) is a bile acid nuclear receptor that plays a crucial role in regulating bile acid and sterol metabolism.
Seth Wander, MD, PhD, discusses the significance of ESR1 mutations in patients with hormone receptor–positive, HER2-negative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results